Literature DB >> 19631346

The effects of daikenchuto (DKT) on propulsive motility in the colon.

Michael J Wood1, Neil H Hyman, Gary M Mawe.   

Abstract

BACKGROUND: The purpose of this study is to examine the use of daikenchuto (DKT), a traditional Japanese medicine, as a potential treatment for opiate-induced slowing of intestinal transit in an isolated guinea pig colon model of motility.
METHODS: Isolated segments of distal guinea pig colon were mounted in a perfusion chamber and imaged with a digital video camera interfaced with a computer. Fecal pellets were inserted into the oral end of the colonic segment and the rates of propulsive motility over a 3 to 4 cm segment of colon were determined in the presence and absence of test compounds. In addition, intracellular recordings were obtained from intact circular muscle, and the responsiveness of inhibitory and excitatory junction potentials to DKT was evaluated.
RESULTS: The addition of D-Ala2, N-Me-Phe4, Gly-ol5 (DAMGO), a selective μ-receptor agonist, caused a concentration dependent decrease in colon motility. Naloxone did not affect basal activity, but partially restored motility in the DAMGO treated preparations. DKT (1 × 10(-4)-3 × 10(-4)g/mL) also reversed the inhibitory effect of DAMGO treated colon in a concentration dependent manner. At higher concentrations (1 × 10(-3)-3 × 10(-3)g/mL), however, this effect was lost. Motility slowed even further when naloxone and DKT were combined with noticeable disruptions in spatiotemporal patterns. Interestingly, when added alone, DKT resulted in reverse peristalsis of the pellet. In electrophysiologic studies DKT inhibited both excitatory and inhibitory junction potentials.
CONCLUSIONS: DKT appears to be as effective as naloxone in restoring motility in DAMGO treated colon. These two agents, however, do not appear to have an additive effect. When used on untreated colon segments, DKT appears to cause disruptions in the intrinsic reflex circuit of the gut resulting in a disruption of neuromuscular communication.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631346      PMCID: PMC2945404          DOI: 10.1016/j.jss.2009.03.068

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

Review 1.  Function of opioids in the enteric nervous system.

Authors:  J D Wood; J J Galligan
Journal:  Neurogastroenterol Motil       Date:  2004-10       Impact factor: 3.598

Review 2.  Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.

Authors:  W K Schmidt
Journal:  Am J Surg       Date:  2001-11       Impact factor: 2.565

3.  Possible role of potassium channels in mu-receptor-mediated inhibition and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.

Authors:  H Nishiwaki; N Saitoh; H Nishio; T Takeuch; F Hata
Journal:  Jpn J Pharmacol       Date:  2000-04

4.  The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats.

Authors:  Hiroyuki Fukuda; Cindy Chen; Christopher Mantyh; Kirk Ludwig; Theodore N Pappas; Toku Takahashi
Journal:  J Surg Res       Date:  2005-11-02       Impact factor: 2.192

5.  5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle.

Authors:  N H Prins; L M Akkermans; R A Lefebvre; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.

Authors:  Conor P Delaney; James L Weese; Neil H Hyman; Joel Bauer; Lee Techner; Kathie Gabriel; Wei Du; William K Schmidt; Bruce A Wallin
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

Review 7.  Alvimopan, a selective peripherally acting mu-opioid antagonist.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2005-04       Impact factor: 3.598

8.  The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs.

Authors:  C Shibata; I Sasaki; H Naito; T Ueno; S Matsuno
Journal:  Surgery       Date:  1999-11       Impact factor: 3.982

9.  Abatement of morphine-induced slowing in gastrointestinal transit by Dai-kenchu-to, a traditional Japanese herbal medicine.

Authors:  Tomonori Nakamura; Akiko Sakai; Issei Isogami; Kazuhiro Noda; Koichi Ueno; Shingo Yano
Journal:  Jpn J Pharmacol       Date:  2002-02

10.  The effect of the herbal medicine dai-kenchu-to on post-operative ileus.

Authors:  T Itoh; J Yamakawa; M Mai; N Yamaguchi; T Kanda
Journal:  J Int Med Res       Date:  2002 Jul-Aug       Impact factor: 1.671

View more
  6 in total

1.  Gastrointestinal Motility Monitor (GIMM).

Authors:  Jill M Hoffman; Elice M Brooks; Gary M Mawe
Journal:  J Vis Exp       Date:  2010-12-01       Impact factor: 1.355

2.  Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs.

Authors:  Kelvin K L Wong; Lauren C Y Tang; Jerry Zhou; Vincent Ho
Journal:  Organogenesis       Date:  2017-02-23       Impact factor: 2.500

3.  The traditional antidiarrheal remedy, Garcinia buchananii stem bark extract, inhibits propulsive motility and fast synaptic potentials in the guinea pig distal colon.

Authors:  O B Balemba; Y Bhattarai; C Stenkamp-Strahm; M S B Lesakit; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2010-08-16       Impact factor: 3.598

4.  Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines.

Authors:  Derek M Kendig; Norm R Hurst; John R Grider
Journal:  J Vis Exp       Date:  2016-01-27       Impact factor: 1.355

5.  Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation.

Authors:  Toshiyuki Kanemasa; Katsumi Koike; Tohko Arai; Hiroko Ono; Narumi Horita; Hiroki Chiba; Atsushi Nakamura; Yasuhide Morioka; Tsuyoshi Kihara; Minoru Hasegawa
Journal:  Neurogastroenterol Motil       Date:  2019-02-28       Impact factor: 3.960

Review 6.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.